We are live on ! Find out more
Envestnet Asset Management

Envestnet Asset Management Portfolio holdings

AUM $424B
1-Year Est. Return 22.96%
 

Envestnet Asset Management, a subsidiary of Envestnet, Inc., founded in 1999 by Jud Bergman and Bill Crager, is a Chicago-based financial technology firm that provides wealth management solutions and software to financial advisors and institutions, managing over $426 billion in discretionary assets as of late 2024. Headquartered at 35 East Wacker Drive, it serves a vast network, including over 111,000 advisors and major U.S. banks, with a platform overseeing more than $6.5 trillion in assets, offering tools like portfolio management, trading, and reporting through an integrated ecosystem. Known for its innovative AdvisorSuite software and Portfolio Management Consultants (PMC) division, Envestnet supports advisors with sub-advisory services, research, and data analytics, bolstered by its 2015 acquisition of Yodlee for enhanced data aggregation. Recently acquired by a Bain Capital-led consortium for $4.5 billion in November 2024, Envestnet continues to evolve as a private entity, focusing on scalable, tech-driven wealth management solutions.

This Fund
S&P 500
This Quarter Est. Return
-5.47%
1 Year Est. Return
+22.96%
3 Year Est. Return
+65.02%
5 Year Est. Return
+65.25%
10 Year Est. Return
+249.9%
AUM
$175B
AUM Growth
-$3.74B
Cap. Flow
+$7.33B
Cap. Flow %
4.18%
Top 10 Hldgs %
25.6%
Holding
4,115
New
205
Increased
2,159
Reduced
1,481
Closed
219

Sector Composition

Rank Sector Weight
1 Technology 5.75%
2 Healthcare 4.62%
3 Financials 3.92%
4 Consumer Discretionary 2.76%
5 Industrials 2.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGEN icon
3851
Compugen
CGEN
$221M
$15K ﹤0.01%
22,986
+4,513
+24% +$6.37K
VRME icon
3852
VerifyMe
VRME
$8.99M
$15K ﹤0.01%
11,629
-216
-2% -$345
BRDS
3853
DELISTED
Bird Global, Inc.
BRDS
$15K ﹤0.01%
1,680
XWEL icon
3854
XWELL
XWEL
$8.06M
$14K ﹤0.01%
918
+325
+55% +$5.75K
RDHL
3855
Redhill Biopharma
RDHL
$3.53M
$13K ﹤0.01%
+25
New +$21.8K
VSTM icon
3856
Verastem
VSTM
$615M
$13K ﹤0.01%
1,251
-36
-3% -$502
MBRX icon
3857
Moleculin Biotech
MBRX
$3.06M
$12K ﹤0.01%
+29
New +$16.8K
CRVS icon
3858
Corvus Pharmaceuticals
CRVS
$1.16B
$9K ﹤0.01%
10,500
DRRX
3859
DELISTED
DURECT Corp
DRRX
$9K ﹤0.01%
1,598
+32
+2% +$195
MBIO icon
3860
Mustang Bio
MBIO
$4.47M
$9K ﹤0.01%
27
-89
-77% -$41.2K
NCMI icon
3861
National CineMedia
NCMI
$370M
$7K ﹤0.01%
1,145
+115
+11% +$1.39K
SOGP
3862
Sound Group
SOGP
$49.3M
$7K ﹤0.01%
1,161
MITO
3863
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$7K ﹤0.01%
23,248
+5,404
+30% +$1.54K
DWTX
3864
Dogwood Therapeutics
DWTX
$61.5M
$6K ﹤0.01%
+646
New +$91K
LITS
3865
Lite Strategy Inc
LITS
$29.6M
$5K ﹤0.01%
+678
New +$7K
BINI
3866
DELISTED
Bollinger Innovations
BINI
0
SVRN
3867
OceanPal Inc
SVRN
$11.8M
0
AWH
3868
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$4K ﹤0.01%
756
+1
+0.1% +$11
SNMP
3869
DELISTED
Evolve Transition Infrastructure LP
SNMP
$4K ﹤0.01%
393
CFRX
3870
DELISTED
ContraFect Corporation
CFRX
$2K ﹤0.01%
141
ADT icon
3871
ADT
ADT
$5.49B
-17,889
Closed -$110K
AKR icon
3872
Acadia Realty Trust
AKR
$2.78B
-14,032
Closed -$219K
ALKS icon
3873
Alkermes
ALKS
$8.29B
-21,967
Closed -$654K
AMPH icon
3874
Amphastar Pharmaceuticals
AMPH
$864M
-6,053
Closed -$211K
AMRX icon
3875
Amneal Pharmaceuticals
AMRX
$5.71B
-20,295
Closed -$65K

Similar funds

Envestnet Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Envestnet Asset Management held 4,115 positions worth $175B, down 2.1% from $179B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Envestnet Asset Management deployed $7.33B of net new capital in Q3 2022, opening 205 new positions and adding to 2,159 existing holdings. Its largest new stake was GSK: 622,292 shares worth $18.3M.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 5.9% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $1.23B trimmed.

  • Envestnet Asset Management's largest Q3 2022 buy was GSK: 622,292 shares worth $18.3M.
  • Envestnet Asset Management added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $1.9B increase.
  • Envestnet Asset Management's biggest Q3 2022 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $1.23B.
  • Envestnet Asset Management fully exited Atlassian in Q3 2022, selling an estimated $67.3M.
  • Envestnet Asset Management's ten largest holdings make up 26% of its $175B portfolio in Q3 2022.
  • Envestnet Asset Management opened 205 new positions and closed 219 in Q3 2022.
  • Envestnet Asset Management's portfolio value fell 2.1% quarter-over-quarter to $175B.

Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.